GLP-1 Research Protocol — Semaglutide dose escalation framework

Standard dose escalation protocol based on the STEP clinical trial parameters. The gradual titration is critical for managing GI side effects based on the published literature.

This mirrors the approach used in the phase 3 trials that led to FDA approval of the branded versions.